financetom
Business
financetom
/
Business
/
Atlas Engineered Products Up 2.2% As Q2 Profit Falls Slightly, But Revenue Rises 34%; Provides Robotics Update
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlas Engineered Products Up 2.2% As Q2 Profit Falls Slightly, But Revenue Rises 34%; Provides Robotics Update
Aug 19, 2024 7:43 AM

10:25 AM EDT, 08/19/2024 (MT Newswires) -- Atlas Engineered Products ( APEUF ) was at last look up more than 2% after saying Monday second quarter net income fell slightly, but revenue rose 34% and it talked of an "exciting future with robotics automation".

The company, which operates in the truss and engineered products industry, reported net income after adjustments and taxes of $0.705 million, or $0.01 per basic and fully diluted share, compared with near $0.8 million, or $0.01 per share, last year. The decrease was primarily due to the amortization related to the intangible assets of the LCF acquisition.

Revenue rose 34% to $15.1 million, from $11.2 million. The company ended the quarter with a strong cash position of $20 million.

In a robotic update, Atlas said it has allocated some of the near $14.6 million raised from financings which closed at the end of June towards expansion at locations in Ontario, New Brunswick, and British Columbia. It added the first deposits have been placed and the robots are expected to be delivered in 2025 and 2026. Staff numbers are being bolstered to help prepare for the increased capacity at each of these locations. The company will release more information on the implementation of robotics during the third quarter of 2024.

Hadi Abassi, President and CEO of AEP, in a statement said: "We expect lower interest rates and structural housing shortages in Canada to create a vibrant environment for activity in the future, however, there is transition period that continues to be challenging for the industry. Notwithstanding that, the company generated healthy margins in the quarter and is managing expenses to produce strong bottom line results. We are very pleased with the contribution from LCF and see a compelling acquisition environment to further build out the platform that we have established in Canada. We continue to strategically balance the need for sales with the gross margin that is attainable in a more competitive market, all while preparing for an exciting future with robotics automation."

Atlas is up $0.03, to $1.34 on the TSX Venture Exchange.

Price: 1.34, Change: +0.03, Percent Change: +2.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DoubleVerify Q1 Results, 2024 Outlook Raise Questions on Growth Prospects, Morgan Stanley Says
DoubleVerify Q1 Results, 2024 Outlook Raise Questions on Growth Prospects, Morgan Stanley Says
Jun 25, 2024
12:10 PM EDT, 06/25/2024 (MT Newswires) -- DoubleVerify's ( DV ) disappointing Q1 results and its 2024 guidance raise questions about the company's growth prospects, Morgan Stanley said in a Tuesday note. Morgan Stanley said the firm now needs to address concerns around slower large customer growth, softer open web ad spend and weaker product fit in CTV/social. While we...
Why GlycoMimetics Stock is Trading Higher Monday
Why GlycoMimetics Stock is Trading Higher Monday
Jun 25, 2024
GlycoMimetics, Inc. ( GLYC ) stock is moving higher Monday after its chief medical officer disclosed the purchase of company stock. The Details: On Tuesday, the chief medical officer Edwin Rock disclosed in a Form4 that he bought 305,000 shares of the company. Rock purchased the shares at an average price of 26 cents. How To Buy GlycoMimetics Stock An...
Why Swimming Pool Supplies Provider Pool Corp Shares Are Diving Today
Why Swimming Pool Supplies Provider Pool Corp Shares Are Diving Today
Jun 25, 2024
Pool Corporation ( POOL ) shares are tumbling today after the company after the company cut its FY24 EPS guidance. Yesterday, the company cut its EPS outlook to $11.04 – $11.44 (from $13.19 – $14.19) vs. estimate of $13.15. Moreover, Pool projects new pool units to decline by 15% to 20% in 2024, and remodeling activity to decrease by up to 15%, vs prior guidance of...
ImmunoPrecise Antibodies Unit, PGxAI to Develop AI Model to Predict Treatment Responses
ImmunoPrecise Antibodies Unit, PGxAI to Develop AI Model to Predict Treatment Responses
Jun 25, 2024
12:12 PM EDT, 06/25/2024 (MT Newswires) -- ImmunoPrecise Antibodies ( IPA ) said Tuesday its BioStrand unit is partnering with PGxAI to create an adaptive artificial intelligence model to predict patient responses to drugs, transforming personalized medicine. Financial details of the partnership weren't disclosed. PGxAI will utilize BioStrand's foundation AI model LENSai to develop an AI model for pharmacogenomics, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved